AOD-9604 Peptide: In-Vitro Fragment Research
AOD-9604, the modified hGH fragment 177-191: how it is used as an in-vitro tool compound to study growth-hormone structure-function. Research use only.
AOD-9604 is a synthetic 16-amino-acid peptide corresponding to the C-terminal fragment (residues 177-191) of human growth hormone (hGH), with an additional N-terminal tyrosine and a stabilising disulphide bond. It is studied as a tool compound for dissecting the structure-function relationships of growth hormone.
Structure and identity
Unlike full-length hGH, AOD-9604 does not bind the classical hGH receptor with significant affinity in standard binding assays. This restricted receptor profile is precisely what makes it useful to researchers seeking to separate the individual signalling domains of growth hormone.
What the research literature examines
In-vitro studies have used AOD-9604 as a tool compound to probe the structure–function relationships of the growth-hormone C-terminal region in cell-culture systems. This body of work is mechanistic. Vivera Labs makes no claims regarding effects in humans, and the compound is supplied strictly for in-vitro laboratory research.
Why purity matters for this peptide
Fragment peptides with disulphide bonds require correct folding and high purity for reproducible results. Each Vivera batch is independently analysed by a US-based third-party laboratory, with a Certificate of Analysis available on request.
Identity confirmed by mass spectrometry Purity quantified by HPLC Disulphide integrity preserved by lyophilisation Batch-specific documentation Researchers are encouraged to evaluate the primary literature directly rather than rely on summaries.
Frequently Asked Questions What is AOD-9604? AOD-9604 is a synthetic 16-amino-acid peptide corresponding to the C-terminal fragment (residues 177-191) of human growth hormone, with an additional N-terminal tyrosine and a stabilising disulphide bond. It is studied as a tool compound for dissecting the structure-function relationships of growth hormone. Vivera Labs makes no claims regarding effects in humans, and the compound is supplied strictly for in-vitro laboratory research.
Does AOD-9604 bind the growth hormone receptor? Unlike full-length hGH, AOD-9604 does not bind the classical hGH receptor with significant affinity in standard binding assays. This restricted receptor profile is precisely what makes it useful to researchers seeking to separate the individual signalling domains of growth hormone.
What does AOD-9604 research examine? In-vitro studies have used AOD-9604 as a tool compound to probe the structure–function relationships of the growth-hormone C-terminal region in cell-culture systems. This body of work is mechanistic. Vivera Labs makes no claims regarding effects in humans, and the compound is supplied strictly for in-vitro laboratory research.
Why does purity matter for AOD-9604? Fragment peptides with disulphide bonds require correct folding and high purity for reproducible results. Each Vivera batch is independently analysed by a US-based third-party laboratory, with identity confirmed by mass spectrometry, purity quantified by HPLC, and disulphide integrity preserved by lyophilisation. A Certificate of Analysis is available on request.
Related
Continue reading
For in-vitro laboratory research use only. Not for human or veterinary use, consumption, or therapeutic application. No medical claims are made.
